Ligand Pharmaceuticals Market Cap

Ligand Pharmaceuticals has a market cap or net worth of €3.5 billion as of January 9, 2026. Its market cap has increased by 69.07% in one year.

Market Cap

3.50B

Enterprise Value

3.31B

Revenue

214.13M

Ranking

n/a

PE Ratio

84.45

Stock Price

€167.00

Market Cap Chart

Since November 25, 1994, Ligand Pharmaceuticals's market cap has increased from 62.10M to 3.50B, an increase of 5,530.64%. That is a compound annual growth rate of 13.82%.

Market Cap History

Date	Market Cap	% Change
Jan 9, 2026	3.50B	10.32%
Dec 31, 2025	3.17B	62.07%
Dec 31, 2024	1.96B	73.58%
Dec 29, 2023	1.13B	6.69%
Dec 30, 2022	1.06B	-53.48%
Dec 31, 2021	2.27B	73.60%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SAP SE	247.30B
Siemens Aktiengesellschaft	197.59B
Allianz SE	145.37B
Deutsche Telekom AG	134.99B
Siemens Energy AG	107.65B
Rheinmetall AG	87.17B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München	67.47B
Deutsche Bank Aktiengesellschaft	63.02B

Market Cap Rankings